The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
APOE genotype and sex affect microglial interactions with plaques in Alzheimer’s disease mice
Open accessAbstract
Microglia affect Alzheimer's disease (AD) pathogenesis in opposing manners, by protecting against amyloid accumulation in early phases of the disease and promoting neuropathology in advanced stages. Recent research has identified specific microglial interactions with amyloid plaques that exert important protective functions including attenuation of early pathology. It is unknown how these protective microglial interactions with plaques are affected by apolipoprotein E (APOE) genotype and sex, two well-established AD risk factors that modulate microglial function. We investigated this question using quantitative confocal microscopy to compare microglial interactions with amyloid plaques in male and female EFAD mice across APOE3 and APOE4 genotypes at 6 months of age. We observed that microglial coverage of plaques is highest in male APOE3 mice with significant reductions in coverage observed with both APOE4 genotype and female sex. Plaque compaction, a beneficial consequence of microglial interactions with plaques, showed a similar pattern in which APOE4 genotype and female sex were associated with significantly lower values. Within the plaque environment, microglial expression of triggering receptor expressed on myeloid cells 2 (TREM2), a known regulator of microglial plaque coverage, was highest in male APOE3 mice and reduced by APOE4 genotype and female sex. These differences in plaque interactions were unrelated to the number of microglial processes in the plaque environment across groups. Interestingly, the pattern of amyloid burden across groups was opposite to that of microglial plaque coverage, with APOE4 genotype and female sex showing the highest amyloid levels. These findings suggest a possible mechanism by which microglia may contribute to the increased AD risk associated with APOE4 genotype and female sex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reactive microglia migrate towards Aβ plaques, surround them and upregulate APOE, which binds to TREM2 and promotes plaque compaction154.”
From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [154]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous reports have demonstrated that gender can affect AD pathology, microglia response and APOE expression (Stephen et al, 2019; Thomas et al, 2016; Sala Frigerio et al, 2019), while the protective and disease causing effects of APOE2 and APOE4 are variable in different ethnic populations (Farrer et al, 1997; Naslavsky et al, 2022).”
From APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia (2024) · cites this paper as Stephen et al, 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“They discovered that microglial coverage of amyloid plaques is highest in male APOE3 mice and reduced by female sex and APOE4 genotype.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
the Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
The microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511
Cited by
Sorted by citations
Mechanisms of sex differences in Alzheimer’s disease
Lopez-Lee, C., Torres, E. R. S., Carling, G., & Gan, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.01.024 · Cited by 376
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease
Parhizkar, S., & Holtzman, D. M. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101594 · Cited by 255
Multifaceted roles of APOE in Alzheimer disease
Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00988-2 · Cited by 193
Sex Differences in Alzheimer’s Disease: Insights From the Multiomics Landscape
Guo, L., Zhong, M. B., Zhang, L., Zhang, B., & Cai, D. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.968 · Cited by 164
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine
Lynch, M. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.868448 · Cited by 146
The role of innate immunity in Alzheimer's disease
Ennerfelt, H. E., & Lukens, J. R. (2020) · Immunological Reviews · doi:10.1111/imr.12896 · Cited by 124
Jayaraj, R. L., Azimullah, S., & Beiram, R. (2019) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2019.12.028 · Cited by 107
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease
Eissman, J. M., Dumitrescu, L. C., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., Scollard, P., Choi, S. E., Bush, W. S., Engelman, C. D., et al. (2022) · Brain · doi:10.1093/brain/awac177 · Cited by 103
Sex-specific effects of microglial activation on Alzheimer’s disease proteinopathy in older adults
Casaletto, K. B., Nichols, E., Aslanyan, V., Simone, S. M., Rabin, J. S., Joie, R. L., Brickman, A. M., Dams-O’Connor, K., Palta, P., Kumar, R. G., et al. (2022) · Brain · doi:10.1093/brain/awac257 · Cited by 92
Shifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84
Chowen, J. A., & García‐Segura, L. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111473 · Cited by 92
Sex difference in human diseases: mechanistic insights and clinical implications
Shi, Y., Ma, J., Li, S., Liu, C., Liu, Y., Chen, J., Liu, N., Liu, S., & Huang, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01929-7 · Cited by 91
Lewandowski, C. T., Maldonado Weng, J., & LaDu, M. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104811 · Cited by 72
Self-citationRangan, P., Lobo, F., Parrella, E., Rochette, N. C., Morselli, M., Stephen, T., Cremonini, A. L., Tagliafico, L., Persia, A., Caffa, I., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111417 · Cited by 73
Self-citationApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels
Steward, A., Biel, D., Dewenter, A., Roemer, S., Wagner, F., Dehsarvi, A., Rathore, S., Otero Svaldi, D., Higgins, I., Brendel, M., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.4038 · Cited by 67
Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway
Narasimhan, S., Holtzman, D. M., Apostolova, L. G., Cruchaga, C., Masters, C. L., Hardy, J., Villemagne, V. L., Bell, J. S., Cho, M., & Hampel, H. J. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01669-5 · Cited by 70
Mielke, M. M. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2019.030023 · Cited by 67
Role of estrogen in women's Alzheimer's disease risk as modified by APOE
Valencia‐Olvera, A. C., Weng, J. M., Christensen, A., LaDu, M. J., & Pike, C. J. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13209 · Cited by 75
Self-citationSex and Gender Differences in Alzheimer’s Disease: Genetic, Hormonal, and Inflammation Impacts
Kolahchi, Z., Henkel, N., Eladawi, M. A., Villarreal, E. C., Kandimalla, P., Lundh, A., McCullumsmith, R. E., & Cuevas, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158485 · Cited by 66
Patel, T., Carnwath, T., Wang, X., Allen, M., Lincoln, S., Lewis‐Tuffin, L. J., Quicksall, Z., Lin, S., Tutor‐New, F. Q., Ho, C. C. G., et al. (2022) · Aging Cell · doi:10.1111/acel.13606 · Cited by 61
Jiang, Y., Zhou, X., Wong, H. Y., Ouyang, L., Ip, F. C. F., Chau, V. M. N., Lau, S., Wu, W., Wong, D. Y. K., Seo, H., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00241-9 · Cited by 56
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01492-x · Cited by 41
Hobel, Z., ageing, F. T. A. D. N. I. A. T. A. I. B. A. L. F. S. O., Isenberg, A. L., Raghupathy, D., Mack, W., & Pa, J. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180859 · Cited by 40
Chen, Y., Hong, T., Chen, F., Sun, Y., Wang, Y., & Cui, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631827 · Cited by 40
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 40
Rocha, S. M., Kirkley, K. S., Chatterjee, D., Aboellail, T., Smeyne, R. J., & Tjalkens, R. B. (2023) · Glia · doi:10.1002/glia.24385 · Cited by 41
Ferguson, C. M., Hildebrand, S. R., Godinho, B. M. D. C., Buchwald, J. E., Echeverria, D., Coles, A. H., Grigorenko, A. P., Vangjeli, L., Sousa, J., McHugh, N., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13703 · Cited by 43
Kloske, C. M., Dugan, A. J., Weekman, E. M., Winder, Z., Patel, E., Nelson, P. T., Fardo, D. W., & Wilcock, D. M. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab085 · Cited by 37
Fu, H., Liu, B., Li, L., & Lemere, C. A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.020 · Cited by 36
Microglial heterogeneity in aging and Alzheimer's disease: Is sex relevant?
Delage, C. I., Šimončičová, E., & Tremblay, M. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.03.006 · Cited by 36
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice
Balu, D., Valencia-Olvera, A. C., Nguyen, A., Patnam, M., York, J., Peri, F., Neumann, F., LaDu, M. J., & Tai, L. M. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01330-6 · Cited by 27
Self-citationPreman, P., Moechars, D., Fertan, E., Wolfs, L., Serneels, L., Shah, D., Lamote, J., Poovathingal, S., Snellinx, A., Mancuso, R., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00162-7 · Cited by 32
The X factor in neurodegeneration
Voskuhl, R. R., & Itoh, Y. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211488 · Cited by 35
Roles of TREM2 in Alzheimer’s disease
Qi, X., Zhu, K., Ke, W., Wang, J., Mao, S., & Chen, G. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00515-3 · Cited by 38
Microglial transcription profiles in mouse and human are driven by APOE4 and sex
Moser, V. A., Workman, M. J., Hurwitz, S. J., Lipman, R. M., Pike, C. J., & Svendsen, C. N. (2021) · iScience · doi:10.1016/j.isci.2021.103238 · Cited by 29
Self-citationSex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Vila‐Castelar, C., Akinci, M., Palpatzis, E., Dominguez, P. A., Operto, G., Kollmorgen, G., Quijano‐Rubio, C., Blennow, K., Zetterberg, H., Falcón, C., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02753-9 · Cited by 32
Jones, N. S., Watson, K. Q., & Rebeck, G. W. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02256-2 · Cited by 26
The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype
Demby, T. C., Gross, P. S., Mandelblatt, J. S., Huang, J. K., & Rebeck, G. W. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114609 · Cited by 28
Wu, D., Bi, X., & Chow, H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02987-4 · Cited by 31
Steroid hormones: risk and resilience in women’s Alzheimer disease
Calvo, N., & Einstein, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1159435 · Cited by 27
Essex, A. L., Huot, J. R., Deosthale, P. J., Wagner, A., Figueras, J. H., Davis, A., Damrath, J. G., Pin, F., Wallace, J. M., Bonetto, A., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4572 · Cited by 20
Crivelli, S. M., Luo, Q., van Kruining, D., Giovagnoni, C., Mané-Damas, M., den Hoedt, S., Berkeš, D., de Vries, H. E., Mulder, M. T., Walter, J., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113240 · Cited by 23
Liu, A., Wang, T., Yang, L., & Zhou, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15070675 · Cited by 23
Menopause and Alzheimer’s disease susceptibility: Exploring the potential mechanisms
Breeze, B., Connell, E., Wileman, T., Müller, M. M., Vauzour, D., & Pontifex, M. G. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149170 · Cited by 22
Impact of Alcohol Abuse on Susceptibility to Rare Neurodegenerative Diseases
Araujo, I., Henriksen, A., Gamsby, J. J., & Gulick, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.643273 · Cited by 23
Imbalance in the response of pre- and post-synaptic components to amyloidopathy
Stephen, T., Tamagnini, F., Piegsa, J., Sung, K., Harvey, J., Oliver‐Evans, A., Murray, T. K., Ahmed, Z., Hutton, M. L., Randall, A. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50781-1 · Cited by 23
Self-citationAPOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
Balu, D., Valencia‐Olvera, A. C., Islam, Z., Mielczarek, C., Hansen, A. L., Ramos, T. M. P., York, J. M., LaDu, M. J., & Tai, L. M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1279343 · Cited by 20
Self-citationStephen, T., Breningstall, B. M., Suresh, S., McGill, C. J., & Pike, C. J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02650-4 · Cited by 17
Self-citationMinding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer’s Disease
Reed-Geaghan, E. G., & Keller-Norrell, P. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417377 · Cited by 19
Association between APOE genotype and microglial cell morphology
Kloske, C. M., Gearon, M. D., Weekman, E. M., Rogers, C. B., Patel, E., Bachstetter, A. D., Nelson, P. T., & Wilcock, D. M. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad031 · Cited by 17
APOE ε4 carrier status modifies plasma p‐tau181 concentrations in cognitively healthy super‐seniors
Cooper, J. G., Ghodsi, M., Stukas, S. K., Leach, S. R., Brooks-Wilson, A. R., & Wellington, C. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13804 · Cited by 16
Saveleva, L., Vartiainen, P., Górová, V., Chew, S., Belaya, I., Konttinen, H., Zucchelli, M., Korhonen, P., Kaartinen, E., Kortelainen, M., et al. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.01.001 · Cited by 19
The connection between autophagy and Alzheimer’s disease
Nechushtai, L., Chen, D., Dan, F., & Pinkas‐Kramarski, R. (2025) · Inflammation Research · doi:10.1007/s00011-025-02118-0 · Cited by 19
Liang, N., Harsch, B. A., Zhou, S., Borkowska, A. G., Shearer, G. C., Kaddurah‐Daouk, R., Newman, J. W. I., & Borkowski, K. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101265 · Cited by 15
Saha, P., & Sisodia, S. S. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00426 · Cited by 16
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 18
A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer’s Disease
Chen, H., Chen, F., Zhang, M., Chen, Y., Cui, L., & Liang, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210602 · Cited by 15
A case for seeking sex-specific treatments in Alzheimer’s disease
Lynch, M. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1346621 · Cited by 16
Zhang, W., Wei, Q.-Q., Zhang, T., Wang, C., Chen, J., Wang, J., Xie, X., & Jiang, P. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03170-z · Cited by 14
Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair
Leung, E., & Hazrati, L. (2021) · Brain Communications · doi:10.1093/braincomms/fcab117 · Cited by 14
Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical
Long, J., Liu, S., Shi, Y., Zhang, C., Li, Q., & Ai, Q. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156436 · Cited by 12
The longitudinal trajectory of CSF sTREM2: the alzheimer’s disease neuroimaging initiative
Wang, Y. T., Ye, M., Ji, Q., Liu, Q., Xu, X., & Zhan, Y. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01506-8 · Cited by 13
Second to fourth digit ratio (2D:4D) is associated with dementia in women
Jiang, J., Young, K., & Pike, C. J. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105152 · Cited by 11
Self-citationAnti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
Laversenne, V., Nazeeruddin, S., Källstig, E., Colin, P., Voize, C., & Schneider, B. L. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01069-3 · Cited by 11
Scheinman, S. B., Zaldua, S., Dada, A., Krochmaliuk, K., Dye, K., Marottoli, F. M., Thatcher, G. R. J., & Tai, L. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.628403 · Cited by 11
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 9
Hosseinzadeh, S., Afshari, S., Molaei, S., Rezaei, N., & Dadkhah, M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578206 · Cited by 10
Effects of obesogenic diet and 17β-estradiol in female mice with APOE 3/3, 3/4, and 4/4 genotypes
Christensen, A., McGill, C. J., Qian, W., & Pike, C. J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1415072 · Cited by 9
Self-citationCicero, C. E., Angelini, L., Abbadessa, G., Bruno, M., Fiume, G., Nucera, B., Ornello, R., Arabia, G., Giuliano, L., Guarnieri, B., et al. (2026) · Neurological Sciences · doi:10.1007/s10072-025-08623-8 · Cited by 11
Ng, C. A. S., Biran, L. P., Galvano, E., Mandelblatt, J. S., Vicini, S., & Rebeck, G. W. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105915 · Cited by 9
Three‐dimensional view of microglia—amyloid plaque interactions
Gotkiewicz, M., Capra, J., Miettinen, P. O., Natunen, T., & Tanila, H. (2024) · Glia · doi:10.1002/glia.24628 · Cited by 11
Calcines-Rodríguez, L., Noyes-Martel, N., Becker, J. D., Nguyen, S. K., Osabutey, M., Trojanczyk, L., Majewska, A. K., & O’Banion, M. K. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03659-1 · Cited by 8
More than microglia: myeloid cells and biomarkers in neurodegeneration
Kodosaki, E., Bell, R., Sogorb‐Esteve, A., Wiltshire, K., Zetterberg, H., & Heslegrave, A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1499458 · Cited by 6
McGill, C. J., Christensen, A., Qian, W., Thorwald, M. A., Godoy-Lugo, J. A., Namvari, S., White, O. S., Finch, C. E., Benayoun, B. A., & Pike, C. J. (2025) · Communications Medicine · doi:10.1038/s43856-025-00942-3 · Cited by 4
Self-citationChaigneau, T., Sha, S., Roux, C. M., Aïd, S., Faucher, A., Chantran, Y., Dorothée, G., & Krantic, S. M. (2025) · Glia · doi:10.1002/glia.70029 · Cited by 3
Ferguson, C. M., Hildebrand, S. R., Godinho, B. M. D. C., Buchwald, J. E., Echeverria, D., Coles, A. H., Grigorenko, A. P., Vanjielli, L., Sousa, J., McHugh, N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.28.498012 · Cited by 3
Sadhukhan, D., Mishra, S., Mukherjee, P., Biswas, A., Hui, S. P., Banerjee, T. K., & Biswas, A. (2023) · medRxiv · doi:10.1101/2023.06.21.23291697 · Cited by 3
Rodriguez, L. C., Noyes-Martel, N., Becker, J. D., Majewska, A. K., & O’Banion, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646050 · Cited by 3
TREM2 and APOE are dispensable for microglial clearance of dying neurons revealed by in vivo imaging
Rai, A., Damisah, E. C., Hill, R., Tong, L., & Grutzendler, J. (2025) · iScience · doi:10.1016/j.isci.2025.114559 · Cited by 3
Sex-dependent interferon signaling contributes to female-biased vulnerability in Alzheimer’s disease
López-López, V., Iniesta, G., Galán-Ganga, M., Exposito-Coca, A., Durán-Laforet, V., Bhojwani-Cabrera, A. M., Navarrón, C. M., Guillot-Fernández, M., Venero, J. L., Sanchez-Mut, J. V., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03840-0 · Cited by 4
Fagla, B. M., York, J. M., Christensen, A., Rosa, C. D., Balu, D., Pike, C. J., Tai, L. M., & Buhimschi, I. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-66489-w · Cited by 2
Self-citationSex differences in microglia as a risk factor for Alzheimer’s disease
Delage, C. I., Rendina, D. N., Malacon, K. E., Tremblay, M., & Bilbo, S. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00008-9 · Cited by 2
McGill, C. J., Christensen, A., Qian, W., Thorwald, M. A., Lugo, J. G., Namvari, S., White, O. S., Finch, C. E., Benayoun, B. A., & Pike, C. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.12.584678 · Cited by 2
Self-citationizydorczak, M., Oumov, M., Udhwani, M. V., Fostok, F., Coronas‐Samano, G., Sanganahalli, B. G., Hermán, P., Hyder, F., & Verhagen, J. V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1622135 · Cited by 1
Sex differences in Alzheimer’s disease animal models
Ippati, S., Ittner, L. M., & Ke, Y. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00003-x · Cited by 1
Patel, T., Carnwath, T., Wang, X., Allen, M., Lincoln, S., Lewis‐Tuffin, L. J., Quicksall, Z., Lin, S., Tutor‐New, F. Q., Ho, C. C. G., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-523348/v1 · Cited by 1
TREM2 and APOE do not modulate phagocytic clearance of dying cells in the live mammalian brainPreprint
Damisah, E. C., Rai, A., Hill, R., Тонг, Л., & Grutzendler, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.17.533222 · Cited by 1
Sex-dependent interferon signaling drives female-biased vulnerability in Alzheimer’s diseasePreprint
López-López, V., Iniesta, G., Galán-Ganga, M., Exposito-Coca, A., Bhojwani-Cabrera, A. M., Guillot-Fernández, M., Giralt, A., & López‐Atalaya, J. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.22.671724 · Cited by 1
INVESTIGATING THE ROLE OF VASCULAR ACTIVATION IN ALZHEIMER’S DISEASE-RELATED NEUROINFLAMMATION
Iannucci, J. (2020) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/iannucci-jaclyn-2020
Microglia, TREM2, and Therapeutic Methods of Alzheimer’s Disease
Xu, S., Ji, Y., Sha, T., & Li, H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100203
Patel, T., Carnwath, T., Wang, X., Allen, M., Lincoln, S., Lewis‐Tuffin, L. J., Quicksall, Z., Lin, S., Tutor‐New, F. Q., Ho, C. C. G., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.13.444000
APOE2 Heterozygosity Reduces Hippocampal Soluble Amyloid-β42 Levels in Non-Hyperlipidemic Mice
Valencia‐Olvera, A. C., Balu, D., Moore, A., Shah, M., Ainis, R., Xiang, B., Saleh, Y., Cai, D., LaDu, M. J., & Tai, L. M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231210
Self-citationSadhukhan, D., Mishra, S., Mukherjee, P., Biswas, A., Hui, S. P., Banerjee, T. K., & Biswas, A. (2023) · Austin Alzheimer s and Parkinson s Disease · doi:10.26420/austinalzheimersjparkinsonsdis.2023.1040 · Cited by 3
izydorczak, M., Oumov, M., Udhwani, M. V., Fostok, F., Coronas‐Samano, G., Sanganahalli, B. G., Hermán, P., Hyder, F., & Verhagen, J. V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.20.649712
Ajagbe͓, A. O., Mobolaji, A. A., Onigbinde, O. A., Mosaku, T. J., Oyeleye, B. S., Ajenikoko-Ugbor, E. F., Wadan, A. S., Bello, A. A., Ajenikoko, M. K., & Abijo, A. Z. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106843 · Cited by 1
MicroRNAs as Potential Biomarkers for Alzheimer’s Disease in Women
Huang, S., Zhong, L., Zheng, L. S., & Shi, J. (2025) · Genes · doi:10.3390/genes16080943 · Cited by 1
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26085212
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737959
Laversenne, V., Nazeeruddin, S., Källstig, E., Colin, P., Voize, C., & Schneider, B. L. (2020) · Figshare · doi:10.6084/m9.figshare.13278564
Barber, A. J., del Genio, C. L., Swain, A. B., Pizzi, E. M., Watson, S. C., Tapiavala, V. N., Zanazzi, G. J., & Gaur, A. B. (2024) · Figshare · doi:10.6084/m9.figshare.26737980
Metadata
- Authors
- Stephen, T. L., Cacciottolo, M., Balu, D., Morgan, T. E., LaDu, M. J., Finch, C. E., & Pike, C. J.
- Affiliations
- University of Southern California (US)
- University of Illinois Chicago (US)
- Corresponding author
- Pike, C. J.
- Venue
- Acta Neuropathologica Communications
- Published
- 2019-05-21
- Volume
- 7
- Issue
- 1
- Pages
- 82-82
- ISSN
- 2051-5960 (ISSN-L)
- PMC
- PMC6528326
- OpenAlex
- W2946924931
- Cited by
- 115
- References
- 65
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 30 · 2023: 13 · 2022: 15 · 2021: 17 · 2020: 14 · 2019: 4
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Acta Neuropathologica Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Aging (AG058068)
- Cure Alzheimer's Fund
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, microglia, amyloid plaques, apolipoprotein E, APOE ε4, APOE3, sex differences, TREM2, amyloid burden, neuroprotection
- MeSH terms
- Alzheimer Disease, Animals, Brain, Female, Genotype, Male, Membrane Glycoproteins, Mice, Transgenic, Receptors, Immunologic, Sex Characteristics, Microglia, Apolipoprotein E3, Apolipoprotein E4, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review